We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis (ATOM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00579956
Recruitment Status : Unknown
Verified August 2007 by University of Oxford.
Recruitment status was:  Recruiting
First Posted : December 24, 2007
Last Update Posted : June 4, 2008
Sponsor:
Collaborators:
Information provided by:

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2010
  Estimated Study Completion Date : September 2010
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):